Drug-eluting polymer implants in cancer therapy

Area of Science:

• Biomedical Engineering
• Oncology
• Materials Science

Background:

• Drug-eluting polymer implants provide a parenteral route for targeted cancer chemotherapy.
• These systems facilitate minimally invasive, image-guided placement and localized drug release.
• Increasing use of sensitive biomolecules necessitates advanced drug delivery systems.

Purpose of the Study:

• To review current trends in pre-formed and in situ-forming drug-eluting implants for cancer chemotherapy.
• To discuss the advantages and challenges of existing and emerging technologies.
• To explore innovations in image-guided delivery, mathematical modeling, and combination therapies.

Main Methods:

• Literature review of clinically available and emerging drug-eluting implant technologies.
• Analysis of innovations in image-guided drug delivery.
• Examination of mathematical modeling and combination therapy approaches.

Main Results:

• Pre-formed and in situ-forming implants represent key advancements in localized chemotherapy delivery.
• Image-guided techniques and mathematical modeling enhance the precision and efficacy of these implants.
• Combination therapies involving drug-eluting implants show significant potential.

Conclusions:

• Drug-eluting polymeric implants are crucial for localized cancer chemotherapy.
• These implants, alone or in combination, will be integral to future cancer management.
• Advancements in delivery systems and therapeutic strategies are expanding their role.